Shopping Cart
- Remove All
Your shopping cart is currently empty
PAP-1
🥰Excellent
Catalog No. TQ0179Cas No. 870653-45-5
Alias 5-(4-Phenoxybutoxy)psoralen
PAP-1 (5-(4-Phenoxybutoxy)psoralen) is a selective, orally active Kv1.3 blocker with an EC50 of 2 nM.
PAP-1
🥰Excellent
Purity: 99.68%
Catalog No. TQ0179Alias 5-(4-Phenoxybutoxy)psoralenCas No. 870653-45-5
PAP-1 (5-(4-Phenoxybutoxy)psoralen) is a selective, orally active Kv1.3 blocker with an EC50 of 2 nM.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | 54 € | In Stock | |
| 5 mg | 76 € | In Stock | |
| 10 mg | 131 € | In Stock | |
| 25 mg | 291 € | In Stock | |
| 50 mg | 519 € | In Stock | |
| 100 mg | 549 € | In Stock | |
| 200 mg | 785 € | In Stock | |
| 1 mL x 10 mM (in DMSO) | 87 € | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "PAP-1"
Tannic acid
Cited
Gallotannic acid
T08011401-55-4
Tannic acid (Gallotannic acid) is a novel hERG channel blocker.
- 38 €
Size
QTY
CitedIndapamide
Veroxil, Tertensif, Noranat
T149826807-65-8
Indapamide (Noranat) is a non-thiazide sulphonamide diuretic compound, generally used in the treatment of hypertension, as well as decompensated cardiac failure.
Inquiry
Minoxidil sulfate
U-58838, Minoxidil sulphate
T813583701-22-8
Minoxidil sulfate (U-58838) is the active metabolite required to exert the vasodilatory and hair growing effects of minoxidil.
- 29 €
Size
QTY
Hydrochlorothiazide
HCTZ
T144958-93-5
Hydrochlorothiazide (HCTZ) is a Thiazide Diuretic. The physiologic effect of hydrochlorothiazide is by means of Increased Diuresis.
- 45 €
Size
QTY
Ursodeoxycholic acid Cited
Ursodiol, UDCA
T0700128-13-2
Ursodeoxycholic acid (UDCA) can be used to dissolve gallstones and reduce cholesterol absorption.
- 28 €
Size
QTY
CitedNifedipine Cited
Procardia XL, Procardia, BAY-a-1040, Adalat
T114621829-25-4
Nifedipine (Procardia) is a dihydropyridine calcium channel blocking agent. Nifedipine inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility. This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in some multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents.
- 42 €
Size
QTY
CitedHalothane
Narcotane, Anestan
T0954151-67-7
Halothane (Anestan) is a nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required.
- 42 €
Size
QTY
Cloperastine hydrochloride
HT-11 hydrochloride
T072314984-68-0
Cloperastine hydrochloride (HT-11 hydrochloride) is a type of flavonoid.
- 29 €
Size
QTY
Tetraethylammonium bromide
TEAB, TEA bromide
T836171-91-0
Tetraethylammonium bromide (TEA bromide) can selectively block potassium channels.
- 27 €
Size
QTY
Butamben
Butyl 4-aminobenzoate
T091694-25-7
Butamben (Butyl 4-aminobenzoate) is a long-duration local anesthetic used for the treatment of chronic pain.
- 29 €
Size
QTY
(±)-Naringenin Cited
Salipurpol, Naringenine, Naringenin
TMS217167604-48-2
(±)-Naringenin (Naringenine) is a natural product. It displays vasorelaxant effect on endothelium-denuded vessels via the activation of BKCa channels in myocytes.
- 42 €
Size
QTY
CitedMinoxidil
U10858
T045138304-91-5
Minoxidil (U10858) is an orally administered vasodilator with hair growth stimulatory and antihypertensive effects.
- 47 €
Size
QTY
Select Batch
Purity:99.68%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | PAP-1 (5-(4-Phenoxybutoxy)psoralen) is a selective, orally active Kv1.3 blocker with an EC50 of 2 nM. |
| Targets&IC50 | Kv1.5:45 nM (EC50), Kv1.3:2 nM (EC50) |
| In vitro | PAP-1 blocks Kv1.3 in a use-dependent manner and acts by preferentially binding to the C-type inactivated state of the channel. PAP-1 exhibits 23-fold selectivity over Kv1.5 (EC50: 45 nM), and further displays 33- to 125-fold selectivity over all other Kv1-family channels [1, 2]. PAP-1 (2-100 nM; 30 minutes) suppresses the proliferation of CCR7-TEM cells (IC50: 10 nM) [1]. |
| In vivo | PAP-1 (0.3-3 mg/kg; i.p.; thrice daily for 48 hours) prevents delayed type hypersensitivity (DTH) in Lewis rats [1]. |
| Cell Research | Cell Line: CCR7-TEM cells (anti-CD3 Ab stimulated). Concentration: 2, 10, 25, 100 nM. Incubation Time: 30 minutes [1] |
| Animal Research | Animal Model: 9- to 11- week-old female Lewis rats. Dosage: I.P.; three times daily for 48 hours. Administration: 0.3, 1, 3 mg/kg [1] |
| Alias | 5-(4-Phenoxybutoxy)psoralen |
| Molecular Weight | 350.36 |
| Formula | C21H18O5 |
| Cas No. | 870653-45-5 |
| Smiles | O=c1ccc2c(OCCCCOc3ccccc3)c3ccoc3cc2o1 |
| Relative Density. | 1.269 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (57.08 mM), Sonication is recommended.  H2O: Insoluble | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy PAP-1 | purchase PAP-1 | PAP-1 cost | order PAP-1 | PAP-1 chemical structure | PAP-1 in vivo | PAP-1 in vitro | PAP-1 formula | PAP-1 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.